Geode Capital Management’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.54M Buy
1,977,001
+276,295
+16% +$915K ﹤0.01% 2592
2025
Q1
$4.93M Buy
1,700,706
+46,110
+3% +$134K ﹤0.01% 2662
2024
Q4
$5.89M Sell
1,654,596
-12,919
-0.8% -$46K ﹤0.01% 2665
2024
Q3
$8.31M Buy
1,667,515
+90,543
+6% +$451K ﹤0.01% 2481
2024
Q2
$4.1M Buy
1,576,972
+1,038,516
+193% +$2.7M ﹤0.01% 2842
2024
Q1
$2.29M Buy
538,456
+43,554
+9% +$186K ﹤0.01% 3062
2023
Q4
$1,000K Buy
494,902
+38,337
+8% +$77.5K ﹤0.01% 3359
2023
Q3
$699K Buy
456,565
+45,588
+11% +$69.8K ﹤0.01% 3473
2023
Q2
$678K Buy
410,977
+23,402
+6% +$38.6K ﹤0.01% 3511
2023
Q1
$442K Hold
387,575
﹤0.01% 3687
2022
Q4
$349K Buy
387,575
+21,676
+6% +$19.5K ﹤0.01% 3834
2022
Q3
$428K Buy
365,899
+121,537
+50% +$142K ﹤0.01% 3800
2022
Q2
$156K Sell
244,362
-10,135
-4% -$6.47K ﹤0.01% 4398
2022
Q1
$664K Buy
254,497
+201
+0.1% +$524 ﹤0.01% 3800
2021
Q4
$989K Buy
254,296
+34,656
+16% +$135K ﹤0.01% 3729
2021
Q3
$957K Sell
219,640
-2
-0% -$9 ﹤0.01% 3698
2021
Q2
$871K Sell
219,642
-135,214
-38% -$536K ﹤0.01% 3678
2021
Q1
$1.85M Buy
354,856
+41,532
+13% +$216K ﹤0.01% 3287
2020
Q4
$1.68M Buy
313,324
+37,906
+14% +$203K ﹤0.01% 3170
2020
Q3
$1.34M Buy
275,418
+4,972
+2% +$24.1K ﹤0.01% 3093
2020
Q2
$1.31M Buy
270,446
+121,357
+81% +$590K ﹤0.01% 3054
2020
Q1
$326K Buy
149,089
+61,021
+69% +$133K ﹤0.01% 3402
2019
Q4
$512K Buy
88,068
+56,226
+177% +$327K ﹤0.01% 3494
2019
Q3
$101K Sell
31,842
-1,359
-4% -$4.31K ﹤0.01% 3946
2019
Q2
$139K Sell
33,201
-42,132
-56% -$176K ﹤0.01% 3875
2019
Q1
$520K Buy
75,333
+31,125
+70% +$215K ﹤0.01% 3426
2018
Q4
$278K Buy
44,208
+19,310
+78% +$121K ﹤0.01% 3584
2018
Q3
$435K Buy
+24,898
New +$435K ﹤0.01% 3515